China’s Largest Vaccine Production Base Sets Up In Henan Province
This article was originally published in PharmAsia News
Executive Summary
China's National Engineering Research Center for Viral Bio-Technology has set up its Henan branch at Henan University. At the same time, the center, Henan University and Shangcheng county jointly established the Henan biology valley in Xinyang city, Henan province. With a Phase I investment of RMB 200 million out of a total of RMB 500 million, the biology valley will house China's largest vaccine production base and biopharmaceutical industrialization facility under the National 863 Program. The project plans to realize a production value of RMB five billion in five years and RMB 10 billion in 10 years. The Henan branch will initially develop programs for novel vaccines for influenza, epidemic hemorrhagic fever and cervical cancer. (Click here for more - Chinese language)
You may also be interested in...
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.